The appearance of troglitazone, a potent glucose-lowering agent, marked a notable chapter in the control of type 2 diabetes. However, its removal from the market due to serious hepatotoxicity spurred considerable https://ihannaslet318127.blog5.net/91722765/troglityzone-and-related-thiazolidinediones-a-relative-overview